The expression of PD‐L1 has been suggested to be associated with the efficacy of anti‐PD‐L1/PD‐1 therapy, and elevated PD‐L1 expression in tumor cells causes the exhaustion of CTLs.41 The gene discussed is CD274; the disease is neoplasm.